23 research outputs found

    Strategien für die Melissezüchtung (Melissa officinalis)

    Get PDF
    Es wurden 120 Melisseherkünfte in Feldversuchen evaluiert. In diesem Material wurde die Variabilität für Winterhärte, Gehalt und Zsammensetzung des ätherischen Öls, Rosmarinsäuregehalt und eingeschränkt Blattertrag beschrieben. Die beschriebene Variabilität ermöglichte die Entwicklung homozygoter Linien mit hoher Eigenleistung für die genannten Zuchtziele bis zur I4-Inzuchtgeneration. Die Kreuzung definierter Linien ermöglichte die Schaffung eines neuen Genpools als Ausgansmaterial für die Entwicklung weiterer aussichtsreicher Linien. Stichwörter: Melisse, Melissa officinalis L., Winterhärte, ätherisches Öl, Rosmarinsäure, ZüchtungBreeding strategies for lemon balm (Melissa officinalis)Evaluation was carried out in field experiments with 120 accessions of lemon balm. This material was characterized for winter hardiness, amount and composition of essential oil, amount of rosmarinic acid and, to a certain degree, for yield of leaves. The characterized variability opened the possibility to develop homozygous lines for the mentioned breeding goals up to inbreed generation I4. Crossing of defined lines created a new gene pool of basic material for development of new promising lines. Keywords: lemon balm, Melissa officinalis L., winter hardiness, essential oil, rosmarinic acid, breedin

    COVID-19 government measures and their impact on mental health: a cross-sectional study of older primary care patients in Germany

    Get PDF
    BackgroundWith the outbreak of COVID-19, government measures including social distancing and restrictions of social contacts were imposed to slow the spread of the virus. Since older adults are at increased risk of severe disease, they were particularly affected by these restrictions. These may negatively affect mental health by loneliness and social isolation, which constitute risk factors for depressiveness. We aimed to analyse the impact of perceived restriction due to government measures on depressive symptoms and investigated stress as mediator in an at-risk-population in Germany.MethodsData were collected in April 2020 from the population of the AgeWell.de-study, including individuals with a Cardiovascular Risk Factors, Aging, and Incidence of Dementia (CAIDE) score ≥9, using the depression subscale of the Brief Symptom Inventory (BSI-18) and the Perceived Stress Scale (PSS-4). Feeling restricted due to COVID-19 government measures was surveyed with a standardized questionnaire. Stepwise multivariate regressions using zero-inflated negative binomial models were applied to analyse depressive symptoms, followed by a general structural equation model to assess stress as mediator. Analysis were controlled for sociodemographic factors as well as social support.ResultsWe analysed data from 810 older adults (mean age = 69.9, SD = 5). Feeling restricted due to COVID-19 government measures was linked to increased depressiveness (b = 0.19; p < 0.001). The association was no longer significant when adding stress and covariates (b = 0.04; p = 0.43), while stress was linked to increased depressive symptoms (b = 0.22; p < 0.001). A final model confirms the assumption that the feeling of restriction is mediated by stress (total effect: b = 0.26; p < 0.001).ConclusionWe found evidence that feeling restricted due to COVID-19 government measures is associated with higher levels of depressive symptoms in older adults at increased risk for dementia. The association is mediated by perceived stress. Furthermore, social support was significantly associated with less depressive symptoms. Thus, it is of high relevance to consider possible adverse effects of government measures related to COVID-19 on mental health of older people

    A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases

    Get PDF
    The NOD-like receptor (NLR) family, pyrin domain-containing protein 3 (NLRP3) inflammasome is a component of the inflammatory process, and its aberrant activation is pathogenic in inherited disorders such as cryopyrin-associated periodic syndrome (CAPS) and complex diseases such as multiple sclerosis, type 2 diabetes, Alzheimer's disease and atherosclerosis. We describe the development of MCC950, a potent, selective, small-molecule inhibitor of NLRP3. MCC950 blocked canonical and noncanonical NLRP3 activation at nanomolar concentrations. MCC950 specifically inhibited activation of NLRP3 but not the AIM2, NLRC4 or NLRP1 inflammasomes. MCC950 reduced interleukin-1 beta (IL-1 beta) production in vivo and attenuated the severity of experimental autoimmune encephalomyelitis (EAE), a disease model of multiple sclerosis. Furthermore, MCC950 treatment rescued neonatal lethality in a mouse model of CAPS and was active in ex vivo samples from individuals with Muckle-Wells syndrome. MCC950 is thus a potential therapeutic for NLRP3-associated syndromes, including autoinflammatory and autoimmune diseases, and a tool for further study of the NLRP3 inflammasome in human health and disease

    Characterization of semiconductor materials using synchrotron radiation-based near-field infrared microscopy and nano-FTIR spectroscopy

    Get PDF
    We describe the application of scattering-type near-field optical microscopy to characterize various semiconducting materials using the electron storage ring Metrology Light Source (MLS) as a broadband synchrotron radiation source. For verifying high-resolution imaging and nano-FTIR spectroscopy we performed scans across nanoscale Si-based surface structures. The obtained results demonstrate that a spatial resolution below 40 nm can be achieved, despite the use of a radiation source with an extremely broad emission spectrum. This approach allows not only for the collection of optical information but also enables the acquisition of near-field spectral data in the mid-infrared range. The high sensitivity for spectroscopic material discrimination using synchrotron radiation is presented by recording near-field spectra from thin films composed of different materials used in semiconductor technology, such as SiO2, SiC, SixNy, and TiO2

    Randomized controlled trial of pregabalin for analgesia after surgical treatment of intervertebral disc disease in dogs

    Full text link
    Methods: Dogs were randomly assigned to two groups, with the placebo group receiving opioids alone and the pregabalin group receiving opioids plus pregabalin. Opioid analgesia consisted of 0.6 mg/kg l‐methadone given intravenously at anesthetic induction, followed by 0.2 mg/kg given at 8, 16, and 24 hours after extubation and fentanyl patches applied at the end of surgery. Pregabalin was given orally (4 mg/kg) 1 hour before anesthesia, followed by postoperative treatment three times per day (4 mg/kg) for 5 days. The outcome measures were the treatment‐group differences in peri‐incisional mechanical sensitivity and Glasgow Composite Measure Pain Scale (CMPS‐SF) assessed during the first 5 postoperative days. Pregabalin serum concentrations were measured after 24, 72, and 120 hours. Results: Pregabalin reduced pain levels in the treatment group by a mean of 2.5 CMPS‐SF units (95% confidence interval [CI] = −3.19 to −1.83, P < .001) compared with the control group during the study period. Pregabalin increased the mechanical nociceptive threshold by a mean of 6.89 N per day (95% CI = 1.87‐11.92, P < .001) and of 7.52 N per day (95% CI = 2.29‐12.77, P < .001) during the study period, depending on location. Mean levels of serum pregabalin were 5.1, 4.71, and 3.68 μg/mL at 24, 72, and 120 hours postoperatively, respectively. Conclusion: Postoperative signs of pain after surgical treatment of intervertebral disc herniation (IVDH) were reduced when dogs received perioperative pregabalin rather than opioids alone. Clinical significance: Perioperative pregabalin reduces postoperative pain after surgical treatment of IVDH
    corecore